SkinHealth Systems Inc. SKIN
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 288.56M | 290.05M | 296.12M | 300.79M | 301.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 288.56M | 290.05M | 296.12M | 300.79M | 301.92M |
| Cost of Revenue | 94.60M | 97.60M | 103.90M | 104.43M | 98.25M |
| Gross Profit | 193.96M | 192.45M | 192.22M | 196.36M | 203.67M |
| SG&A Expenses | 181.20M | 190.87M | 197.07M | 211.54M | 218.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 281.65M | 294.36M | 306.70M | 321.59M | 322.04M |
| Operating Income | 6.91M | -4.31M | -10.58M | -20.80M | -20.12M |
| Income Before Tax | -13.19M | -23.73M | -3.55M | -5.94M | -12.85M |
| Income Tax Expenses | 5.10M | 4.71M | 2.51M | 3.58M | -1.10M |
| Earnings from Continuing Operations | -18.29 | -28.43 | -6.05 | -9.52 | -11.75 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.29M | -28.43M | -6.05M | -9.52M | -11.75M |
| EBIT | 6.91M | -4.31M | -10.58M | -20.80M | -20.12M |
| EBITDA | 28.14M | 20.08M | 13.94M | 4.55M | 6.44M |
| EPS Basic | -2.86 | -4.46 | -0.92 | -1.50 | -1.89 |
| Normalized Basic EPS | -1.39 | -2.43 | -0.43 | -0.59 | -0.48 |
| EPS Diluted | -2.91 | -4.51 | -3.50 | -4.03 | -4.42 |
| Normalized Diluted EPS | -1.37 | -2.41 | -0.60 | -0.77 | -0.67 |
| Average Basic Shares Outstanding | 25.75M | 25.59M | 25.41M | 25.27M | 25.12M |
| Average Diluted Shares Outstanding | 25.93M | 25.77M | 26.30M | 25.99M | 25.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |